Article
A new predictive scoring system based on clinical data and computed tomography features for diagnosing EGFR-mutated lung adenocarcinoma.
Current oncology (Toronto, Ont.) - 1 Apr 2018
Cao Y, Xu H
Abstract excerpt
Background: We aimed to develop a new EGFR mutation-predictive scoring system to use in screening for EGFR-mutated lung adenocarcinomas (lacs). Methods: The study enrolled 279 patients with lac, including 121 patients with EGFR wild-type tumours and 158 with EGFR-mutated tumours. The Student t-test, chi-square test, or Fisher exact test was applied to discriminate clinical and computed tomography (ct) features...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
